Release Date: 06/01/09 17:23 Summary: Director and Senior Executive Option Plan Price Sensitive: No Download Document 120.05KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%